In contrast, another study examining SLCO1B3 expression in 102 breast carcinoma samples using IHC found SLCO1B3 expression in 50% of samples, and where immune reactivity was found this was inversely correlated to tumour size and was associated with a lower incidence of BC recurrence. This evidence concerns the gene SLCO1B3 and breast cancer.